abstract |
The present invention provides a peptide compound Gly-Arg-Gly-Asp as a therapeutic agent for the prevention and / or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, cardiovascular diseases and metabolic diseases. It relates to the use of -Asn-Pro-OH. In addition, the present invention optionally comprises a peptide Gly-Arg-Gly-Asp-Asn-Pro- with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and / or diluent. It preferably relates to a pharmaceutical composition containing OH, preferably in the form of a lyophilizate or liquid buffer or artificial breast milk preparation or breast milk substitute. |